Diagnosis

  • Imaging:
    • InitialAbdominal Ultrasound (detects as little as 100 mL of fluid, evaluates liver parenchymal echogenicity, screens for portal vein thrombosis).
  • Gold Standard/Confirmatory Procedure:
    • Diagnostic Paracentesis (indicated for all patients with new-onset ascites or suspected infection/SBP).
  • Key Labs (Ascitic Fluid Analysis):
    • Serum-Ascites Albumin Gradient (SAAG): Serum albumin minus ascitic fluid albumin.
      • SAAG ≥ 1.1 g/dL (indicates portal HTN): Cirrhosis, HF, Budd-Chiari syndrome, portal vein thrombosis.
      • SAAG < 1.1 g/dL (indicates non-portal HTN): Peritoneal carcinomatosis, TB peritonitis, nephrotic syndrome, pancreatitis.
    • Ascitic Fluid Total Protein:
      • < 2.5 g/dL: Cirrhosis, nephrotic syndrome.
      • ≥ 2.5 g/dL: Cardiac ascites (HF), Budd-Chiari, TB peritonitis.
    • Cell Count & DifferentialPMN count ≥ 250/mm³ is diagnostic for Spontaneous Bacterial Peritonitis (SBP).
    • Other tests: Cytology (malignancy), Amylase (pancreatic ascites), Acid-fast bacilli stain/culture (TB).

Management

  • First-line (for Portal HTN-related ascites):
    • Dietary sodium restriction (< 2 g/day).
    • Oral diuretics: Combined therapy with Spironolactone and Furosemide (ratio of 100 mg to 40 mg to maintain potassium balance). c
      • Spironolactone (Aldosterone Antagonist):
        • Primary agent: Addresses the root cause of sodium retention by directly blocking mineralocorticoid receptors in the distal tubule/collecting duct.
        • Prevents reabsorption and potassium () excretion.
        • Limitation: Weak diuretic on its own; slow onset of action (takes 2-4 days to reach full effect).
      • Furosemide (Loop Diuretic):
        • Inhibits cotransporters in the thick ascending limb of the loop of Henle.
        • Potent and fast-acting: Rapidly increases urinary flow and sodium excretion.
        • Limitation: If used alone, the excess delivered downstream to the distal tubule is simply reabsorbed due to the hyperaldosteronism state.
  • Second-line:
    • Large-Volume Paracentesis (LVP) for refractory ascites or tense ascites causing respiratory compromise.
    • Administer IV Albumin (6-8 g per Liter of fluid removed) if > 5 L of fluid is extracted to prevent post-paracentesis circulatory dysfunction.
  • Refractory / Definitive:
    • Transjugular Intrahepatic Portosystemic Shunt (TIPS) (relieves portal HTN; contraindicated in severe hepatic encephalopathy or HF).
    • Liver transplantation.
  • Non-Portal HTN ascites (SAAG < 1.1):
    • Diuretics are generally ineffective; must treat the underlying etiology directly (e.g., chemotherapy for malignancy, anti-TB therapy, steroid therapy for nephrotic syndrome).